Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Association between HbA1c and the development of cystic fibrosis‐related diabetes

Choudhury, M., Taylor, P. ORCID: https://orcid.org/0000-0002-3436-422X, Morgan, P. H. ORCID: https://orcid.org/0000-0002-8555-3493, Duckers, J., Lau, D., George, L., Ketchell, R. I. and Wong, F. S. ORCID: https://orcid.org/0000-0002-2812-8845 2019. Association between HbA1c and the development of cystic fibrosis‐related diabetes. Diabetic Medicine 36 (10) , pp. 1251-1255. 10.1111/dme.13912

[thumbnail of 119798   The Association between HbA1c    Maitrayee revised clean version 201218.pdf]
Preview
PDF - Accepted Post-Print Version
Download (479kB) | Preview

Abstract

Aims To examine HbA1c as a predictor of risk for future development of cystic fibrosis‐related diabetes and to assess the association with the development of retinopathy in people with cystic fibrosis‐related diabetes. Methods A 7‐year retrospective longitudinal study was conducted in 50 adults with cystic fibrosis, comparing oral glucose tolerance test results with HbA1c values in predicting the development of cystic fibrosis‐related diabetes. Retinal screening data were also compared with HbA1c measurements to assess microvascular outcome. Results An HbA1c value ≥37 mmol/mol (5.5%; hazard ratio 3.49, CI 1.5–8.1) was significantly associated with the development of dysglycaemia, as defined by the oral glucose tolerance test over a 7‐year period. Severity of diabetic retinopathy was associated with a higher HbA1c and longer duration of cystic fibrosis‐related diabetes. Conclusion There is a link between HbA1c level and the future development of dysglycaemia in cystic fibrosis based on oral glucose tolerance test, as well as microvascular outcomes. Although current guidance does not advocate the use of HbA1c as a diagnostic tool in cystic fibrosis‐related diabetes, it may be of clinical use in determining individuals at risk of future development of cystic fibrosis‐related diabetes.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Business (Including Economics)
Medicine
Publisher: Wiley
ISSN: 0742-3071
Date of First Compliant Deposit: 18 March 2019
Date of Acceptance: 28 January 2019
Last Modified: 08 Nov 2023 13:11
URI: https://orca.cardiff.ac.uk/id/eprint/119798

Citation Data

Cited 6 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics